Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

COVID-19 Vaccine Provincial Rollout Plans


British Columbia

Alberta

  • Update: May 3, 2021: 
    • Children aged 12 -15 with type 1 diabetes are no longer required to present a doctor’s note when booking a vaccine. Anyone over 16 with type 1 diabetes is also eligible for a vaccine.
  • Update: April 27, 2021
    • We have received many questions about vaccination for children and adolescents with T1D. Below is the latest recommendation from the National Advisory Council on Immunization (NACI)
    • 9. NACI recommends that COVID-19 vaccines should not be offered routinely to individuals who are not in the authorized age group. (Strong NACI Recommendation)
    • a. However, a complete vaccine series with a Pfizer-BioNTech may be offered to individuals 12-15 years of age who are at very high risk of severe outcomes of COVID-19 (e.g., due to a pre-existing medical condition known to be associated with increased risk of hospitalization or mortality) or are at increased risk of exposure (e.g., due to living in a congregate care facility), if a risk assessment deems that the benefits outweigh the potential risks for the individual, and if informed consent with the individual and the parent or guardian includes discussion about the insufficiency of evidence on the use of COVID-19 vaccines in this population. (Discretionary NACI Recommendation)
    • Alberta is currently offering vaccines to individuals in the age group with T1D. We will keep monitoring the rest of Canada and provide updates accordingly once the provincial recommendations on children and adolescents are revised.  

Saskatchewan

Manitoba

Ontario

  • Update: May 3, 2021: 
    • As of May 10, 2021 anyone over 16 with type 1 diabetes can book a vaccine throughout the province.

Quebec

  • People with type 1 diabetes who are 16 years or older can now book a vaccine in the province of Quebec. To book, please click here.

New Brunswick

Nova Scotia

Prince Edward Island

Newfoundland and Labrador

Nunavut

Northwest Territories

Yukon Territory